Session 1.6 | TAVI in Patients With Long-Life Expectancy: The Index Valve Matters

Chair: Nicolas Van Mieghem

Panel: Joanna Wykrzykowska; David Hildick-Smith; Rui Campante Teles

As TAVI expands into younger populations, lifetime management has become a critical consideration. This session explores how initial valve selection influences durability, future reintervention options and long-term patient outcomes.

Through expert presentations and panel discussion, attendees will examine the trade-offs between valve platforms, risks of patient–prosthesis mismatch and the impact of sequential valve interventions. The session also underscores the importance of anatomical assessment and long-term planning, particularly in patients likely to require multiple procedures over their lifetime. This is a must-attend discussion for clinicians aiming to optimise first-time TAVI decisions while preserving future treatment options and avoiding cumulative procedural limitations.